HALO ▲ +1.6% - Halozyme Therapeutics, Inc. $HALO - Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology 06-OCT-2026 04:06 PM ET